Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ORKA

Oruka Therapeutics (ORKA)

Oruka Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORKA
DateTimeSourceHeadlineSymbolCompany
12/19/20247:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
12/19/20247:00AMGlobeNewswire Inc.Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 AntibodyNASDAQ:ORKAOruka Therapeutics Inc
12/18/20247:00AMGlobeNewswire Inc.Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)NASDAQ:ORKAOruka Therapeutics Inc
11/27/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORKAOruka Therapeutics Inc
11/21/20246:30PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
11/21/20246:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
11/19/20248:00AMGlobeNewswire Inc.Oruka Therapeutics to Present at Piper Sandler’s 36th Annual Healthcare ConferenceNASDAQ:ORKAOruka Therapeutics Inc
11/18/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
11/14/20247:38PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
11/14/20245:49PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
11/14/20245:20PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ORKAOruka Therapeutics Inc
11/14/20244:56PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
11/14/202412:04PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
11/14/20249:56AMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
11/14/20246:37AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ORKAOruka Therapeutics Inc
11/13/20244:25PMGlobeNewswire Inc.Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ORKAOruka Therapeutics Inc
11/13/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORKAOruka Therapeutics Inc
11/04/20247:00AMGlobeNewswire Inc.Oruka Therapeutics to Present at Multiple November Investor ConferencesNASDAQ:ORKAOruka Therapeutics Inc
10/22/20244:15PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
10/18/20244:11PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORKAOruka Therapeutics Inc
10/04/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
09/25/20247:08AMGlobeNewswire Inc.Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology CongressNASDAQ:ORKAOruka Therapeutics Inc
09/13/20244:57PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ORKAOruka Therapeutics Inc
09/13/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
09/13/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORKAOruka Therapeutics Inc
09/12/20247:05AMGlobeNewswire Inc.Oruka Therapeutics Announces $200 Million Private PlacementNASDAQ:ORKAOruka Therapeutics Inc
09/12/20247:00AMGlobeNewswire Inc.Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19NASDAQ:ORKAOruka Therapeutics Inc
09/06/20245:08PMEdgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:ORKAOruka Therapeutics Inc
09/06/20245:07PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
09/06/20245:07PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORKAOruka Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ORKA

Your Recent History

Delayed Upgrade Clock